Cell Biotech Co., Ltd.

₩14,630As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:049960Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (8.19%)
Div yield 4.10%
ROE 12.91%
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.48
PE TTM 5.962
TSR TTM 30.23%
Mkt cap ₩100.1B
ROIC 21.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩16,491
12.72%
133.09%
Hold 5|0|5|9|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
290.92
281.30
296.94
328.27
23.61%
8.96%
8.53%
21.11%
Revenue₩B
9.274
9.396
9.683
10.07
(2.68%)
(0.79%)
5.33%
10.59%
Peers (US$73.82M)
Cap (US$)
PE
83.39M
—
77.51M
—
Capital
TTM
5Y
10Y
Leveragex
0.788
0.093
0.090
EBIT/Intx
0.662
0.080
0.112
Own earn%
(599.60)
(61.37)
(51.80)
Sh yield%
11.69
41.75
40.31
Owners
Insiders/Inst%
13.80
84.28
Short interest%
2.22
SBC / revenue%
1.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
32–37
$1 testx
—
Incr. ROIC%
1